Biolase (BIOL) Reports Q4 Loss of $0.07

Biolase (NASDAQ: BIOL) reported Q4 EPS of ($0.07). Revenue for the quarter came in at $13.76 million versus the consensus estimate of $13.23 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c